Cyclooxygenase Inhibition and Adverse Remodeling During Healing After Myocardial Infarction

This publication has 13 references indexed in Scilit:

• Cyclooxygenase-2 Inhibition Increases Mortality, Enhances Left Ventricular Remodeling, and Impairs Systolic Function After Myocardial Infarction in the Pig
  Circulation, 2007
• Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas
  Circulation, 2006
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
  Circulation, 2006
• Cyclooxygenase Inhibition and Cardiovascular Risk
  Circulation, 2005
• Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
  New England Journal of Medicine, 2005
• Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults
  Circulation, 2004
• Of Mice and Dogs
  The American Journal of Pathology, 2004
• Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog
  Canadian Journal of Physiology and Pharmacology, 1988
• Scar thinning due to ibuprofen administration after experimental myocardial infarction
  The American Journal of Cardiology, 1983
• Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog
  The American Journal of Cardiology, 1980